The Systemic Immune-Inflammation Index as an Innovative Prognostic Indicator for Critically Ill Sepsis Patients: Insights from the MIMIC-IV Database and Machine Learning Predictive Analysis - Report - MDSpire

The Systemic Immune-Inflammation Index as an Innovative Prognostic Indicator for Critically Ill Sepsis Patients: Insights from the MIMIC-IV Database and Machine Learning Predictive Analysis

  • By

  • Xudong Zhang

  • Yiquan Xu

  • Yu Lei

  • Miaomiao Tang

  • Yanqing Wang

  • Jianghui Luo

  • Shuying Zhu

  • February 7, 2026

  • 0 min

Share

Clinical Report: The Systemic Immune-Inflammation Index in Sepsis Prognosis

Overview

This study evaluates the prognostic utility of the systemic immune-inflammation index (SII) in critically ill sepsis patients using the MIMIC-IV database. Findings suggest that SII is a significant predictor of both short- and long-term mortality in this population.

Background

Sepsis is a leading cause of mortality in intensive care units, with a high early mortality rate necessitating effective prognostic tools. Traditional prognostic methods often lack accuracy and real-time applicability, highlighting the need for innovative biomarkers like the SII. This index integrates immune response metrics, potentially enhancing risk stratification for sepsis patients.

Data Highlights

No numerical data available in the provided context.

Key Findings

  • The systemic immune-inflammation index (SII) is calculated as (neutrophil × platelet)/lymphocyte.
  • SII reflects the balance between innate and adaptive immune responses, crucial in sepsis prognosis.
  • Higher SII values correlate with increased short- and long-term mortality in sepsis patients.
  • The study utilized machine learning techniques to enhance predictive modeling of mortality based on SII.
  • Model explainability techniques were applied to identify key predictors influencing mortality outcomes.

Clinical Implications

The SII may serve as a valuable tool for clinicians to identify high-risk sepsis patients and tailor early interventions. Incorporating SII into clinical practice could improve risk stratification and potentially reduce mortality rates in critically ill patients.

Conclusion

The systemic immune-inflammation index is a promising prognostic indicator for critically ill sepsis patients, warranting further validation in clinical settings. Its integration into predictive models may enhance patient management and outcomes.

References

  1. Critical Care (Springer), 2025 -- Predictive enrichment using biomarkers in studies of critically-ill patients with sepsis: a systematic review
  2. Infection, 2023 -- Identifying Sepsis Mimics in Patients Admitted to Intensive Care: A Retrospective Observational Analysis
  3. Infection, 2022 -- A Two-Year Retrospective Study on the Prognostic Significance of MqSOFA in Comparison to Lactate, NEWS, and qSOFA in Sepsis Patients
  4. Critical Care (Springer), 2025 -- Comprehensive Review and Meta-Analysis of Humoral Immune Proteins and Their Association with Mortality in Sepsis
  5. Surviving Sepsis Campaign Adult Guidelines | SCCM
  6. Restrictive volume treatment in septic shock: the CLASSIC Trial
  7. Systemic immune-inflammation index and the short-term mortality of patients with sepsis: A meta-analysis
  8. Surviving Sepsis Campaign Adult Guidelines | SCCM

Original Source(s)

Related Content